Research ArticleClinical Studies

Paclitaxel and Pegylated Liposomal Doxorubicin in Recurrent Head and Neck Cancer: Clinical and Unexpected Pharmacokinetic Interactions

MARIO AIROLDI, LUIGI CATTEL, PAOLA MILLA, FULVIA PEDANI, MASSIMILIANO GARZARO and FRANCO DOSIO
Anticancer Research July 2008, 28 (4C) 2519-2527;

Article Information

vol. 28 no. 4C 2519-2527
PubMed 
18751444
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 27, 2008
  • Revision received June 2, 2008
  • Accepted June 3, 2008
  • Published online July 1, 2008.
Copyright & Usage 
Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MARIO AIROLDI1,
  2. LUIGI CATTEL2,
  3. PAOLA MILLA2,
  4. FULVIA PEDANI1,
  5. MASSIMILIANO GARZARO3 and
  6. FRANCO DOSIO2
  1. 1Medical Oncology Department, San Giovanni Antica Sede Hospital, Turin
  2. 2Departments of Drug Science & Technology, Turin University, Turin, Italy
  3. 3ENT, Turin University, Turin, Italy
  1. Correspondence to: Dr. Mario Airoldi, Medical Oncology Department, San Giovanni Antica Sede Hospital, Via Cavour 31, 10123 Turin, Italy. Tel: +390116333545, Fax: +390116333591, e-mail: airoldim{at}yahoo.com

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Paclitaxel and Pegylated Liposomal Doxorubicin in Recurrent Head and Neck Cancer: Clinical and Unexpected Pharmacokinetic Interactions
MARIO AIROLDI, LUIGI CATTEL, PAOLA MILLA, FULVIA PEDANI, MASSIMILIANO GARZARO, FRANCO DOSIO
Anticancer Research Jul 2008, 28 (4C) 2519-2527;
Twitter logo Facebook logo Mendeley logo

Jump to section